Prosecution Insights
Prosecution Insights
5 pending office actions • 5 art units • 5 examiners • 0 of 5 (0%) have an AI response strategy ready • 4 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 4 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 4 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 only | 1 (20%) |
| §103 only | 1 (20%) |
| §112 only | 1 (20%) |
| Multi-statute (no §101) | 2 (40%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| WALTERS JR, ROBERT S | 1 | 51.5% | +50.5% |
| WHITEMAN, BRIAN A | 1 | 68.4% | +16.7% |
| HILL, MYRON G | 1 | 66.3% | +20.1% |
| GHIMIRE, SHANKAR RAJ | 1 | 76.8% | +18.7% |
| PULLIAM, JOSEPH CONSTANTINE | 1 | 37.3% | +28.9% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17068546 | IMMUNE RECEPTOR ANALYSIS AS DIAGNOSTIC ASSAY | PULLIAM, JOSEPH CONSTANTINE | 36d overdue |
| 18043520 | DUX4 INHIBITORS AND METHODS OF USE THEREOF | WHITEMAN, BRIAN A | 2d overdue |
| 18061047 | URINARY CATHETER FOR ENDOSCOPE | GHIMIRE, SHANKAR RAJ | 28d |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 5 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17068546 | IMMUNE RECEPTOR ANALYSIS AS DIAGNOSTIC ASSAY | PULLIAM, JOSEPH CONSTANTINE | 36d overdue |
| 18043520 | DUX4 INHIBITORS AND METHODS OF USE THEREOF | WHITEMAN, BRIAN A | 2d overdue |
| 18178368 | DIRECT METHOD OF SYNTHESIS OF ZNO NWS/SWCNTS AND ZNO NWS/GRAPHENE HETEROSTRUCTURES | WALTERS JR, ROBERT S | 19d |
| 18061047 | URINARY CATHETER FOR ENDOSCOPE | GHIMIRE, SHANKAR RAJ | 28d |
| 18160926 | HEPATITIS C VIRUS MODIFIED E2 GLYCOPROTEIN AND USES THEREOF AS VACCINES | HILL, MYRON G | — |
| Art Unit | Apps |
|---|---|
| 1717 | 1 |
| 1636 | 1 |
| 1671 | 1 |
| 3795 | 1 |
| 1687 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18178368 | DIRECT METHOD OF SYNTHESIS OF ZNO NWS/SWCNTS AND ZNO NWS/GRAPHENE HETEROSTRUCTURES | WALTERS JR, ROBERT S | 1717 | §103 | Non-Final OA | 19d | Pending | Mar 03, 2023 |
| 18043520 | DUX4 INHIBITORS AND METHODS OF USE THEREOF | WHITEMAN, BRIAN A | 1636 | §103§112 | Final Rejection | 2d overdue | Pending | Feb 28, 2023 |
| 18160926 | HEPATITIS C VIRUS MODIFIED E2 GLYCOPROTEIN AND USES THEREOF AS VACCINES | HILL, MYRON G | 1671 | §112 | Non-Final OA | — | Pending | Jan 27, 2023 |
| 18061047 | URINARY CATHETER FOR ENDOSCOPE | GHIMIRE, SHANKAR RAJ | 3795 | §103§112 | Non-Final OA | 28d | Pending | Dec 02, 2022 |
| 17068546 | IMMUNE RECEPTOR ANALYSIS AS DIAGNOSTIC ASSAY | PULLIAM, JOSEPH CONSTANTINE | 1687 | §101 | Final Rejection | 36d overdue | Pending | Oct 12, 2020 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial